News
Agile Analytics & Operational Intelligence for COVID-19
The global outbreak of SARS-CoV-2 (COVID-19) has been filled with uncertainty. Who is most at risk? Which symptoms are most common? What treatments are effective? The incredibly varied presentation, from asymptomatic patients to mortality further complicates assessing the true scope of infection and drives further uncertainty in how to respond to and manage the pandemic. Rapid turnaround in research from China and other locations with some of the first cases has provided invaluable information to guide the next stage of research and treatment. However, as large-scale clinical trials are difficult to deploy rapidly, much of the next wave will rely on real-world data (RWD) and observational studies paired with basic and translational research to guide the response to and management of COVID-19.
Source: Medium